Common Contracts
18 similar null contracts by Great Ajax Corp., Lyra Therapeutics, Inc., Adicet Bio, Inc., others
LYRA THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Amended and Restated Controlled Equity OfferingSM Sales AgreementLyra Therapeutics, Inc. • March 22nd, 2024 • Surgical & medical instruments & apparatus • New York
Lyra Therapeutics, Inc., a Delaware corporation (the “Company”), and Cantor Fitzgerald & Co. (the “Agent”), are parties to that certain Sales Agreement dated September 1, 2023 (the “Original Agreement”). The Company and the Agent desire to amend and restate the Original Agreement in its entirety as set forth in this Amended and Restated Sales Agreement (this “Agreement”).
Certain confidential information contained in this document, marked by [***], has been omitted because Iris Energy Limited (the “Company”) has determined that the information (i) is not material and (ii) contains personal information. IRIS ENERGY...Iris Energy LTD • September 13th, 2023 • Finance services • New York
LYRA THERAPEUTICS, INC. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementLyra Therapeutics, Inc. • September 1st, 2023 • Surgical & medical instruments & apparatus • New York
Lyra Therapeutics, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Riot Platforms, Inc. Shares of Common Stock (no par value per share) Controlled Equity OfferingSM Sales AgreementRiot Platforms, Inc. • August 9th, 2023 • Finance services • New York
Riot Platforms, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co., B. Riley Securities, Inc., BTIG, LLC, Roth Capital Partners, LLC, Compass Point Research & Trading, LLC, Northland Securities, Inc., Moelis & Company LLC, and Stifel Nicolaus Canada Inc. (collectively, the “Agents,” and individually, an “Agent”), as follows:
SoundHound AI, Inc. Shares of Common Stock (par value $0.0001 per share) Controlled Equity Offering Sales AgreementSoundhound Ai, Inc. • July 24th, 2023 • Services-prepackaged software • New York
GENENTA SCIENCE S.P.A. American Depositary Shares each representing one ordinary share, no par value per share Controlled Equity OfferingSM Sales AgreementGenenta Science S.p.A. • May 12th, 2023 • Biological products, (no disgnostic substances) • New York
Genenta Science S.p.A., a Republic of Italy joint stock corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Perpetua Resources Corp. Common Shares (without par value) Controlled Equity OfferingSM Sales AgreementPerpetua Resources Corp. • May 12th, 2023 • Gold and silver ores • New York
Perpetua Resources Corp., a corporation incorporated under the Business Corporations Act (British Columbia) (the “BCBCA”) and having its head office located in Boise, Idaho (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Mind Medicine (MindMed) Inc. Common Shares (no par value per share) Controlled Equity OfferingSM Sales AgreementMind Medicine (MindMed) Inc. • May 4th, 2022 • Medicinal chemicals & botanical products • New York
Mind Medicine (MindMed) Inc., a corporation organized under the laws of the Province of British Columbia (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. and Oppenheimer & Co. Inc. (each, an “Agent,” and together, the “Agents”), as follows:
KalVista Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementKalVista Pharmaceuticals, Inc. • May 21st, 2021 • Pharmaceutical preparations • New York
KalVista Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Zynerba Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementZynerba Pharmaceuticals, Inc. • May 12th, 2021 • Pharmaceutical preparations • New York
Zynerba Pharmaceuticals, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co., Canaccord Genuity LLC, H.C. Wainwright & Co., LLC and Ladenburg Thalmann & Co. Inc. (each, an “Agent,” and collectively, the “Agents”), as follows:
TherapeuticsMD, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementTherapeuticsMD, Inc. • March 4th, 2021 • Pharmaceutical preparations • New York
TherapeuticsMD, Inc., a Nevada corporation (the “Company”), confirms its agreement (this “Agreement”) with Cantor Fitzgerald & Co. (the “Agent”), as follows:
Adicet Bio, Inc. Shares of Common Stock (par value $0.0001 per share) Sales AgreementAdicet Bio, Inc. • December 1st, 2020 • Pharmaceutical preparations • New York
Adicet Bio, Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with Evercore Group L.L.C. and H.C. Wainwright & Co., LLC (each individually an “Agent” and collectively, the “Agents”) as follows:
NOVAVAX, INC. Common Stock (par value $0.01 per share) AT MARKET ISSUANCE SALES AGREEMENTNovavax Inc • November 10th, 2020 • Biological products, (no disgnostic substances) • New York
X4 Pharmaceuticals, Inc. Shares of Common Stock (par value $0.001 per share) Controlled Equity OfferingSM Sales AgreementX4 Pharmaceuticals, Inc • August 7th, 2020 • Biological products, (no disgnostic substances) • New York
PFENEX INC. Common Stock (par value $0.001 per share) Equity Sales AgreementPfenex Inc. • March 15th, 2018 • Pharmaceutical preparations • New York
Pfenex Inc., a Delaware corporation (the “Company”), confirms its agreement (this “Agreement”) with William Blair & Company, L.L.C. (the “Agent”) as follows:
Great Ajax Corp. Common Stock (par value $0.01 per share)Great Ajax Corp. • October 3rd, 2016 • Real estate investment trusts • New York
Great Ajax Corp., a Maryland corporation (the “Company”), Great Ajax Operating Partnership LP, a Delaware limited partnership (the “Operating Partnership”), and Thetis Asset Management LLC, a Delaware limited liability company (the “Manager”), each confirms its agreement (this “Agreement”), with Raymond James & Associates, Inc. (the “Agent”), as follows:
Great Ajax Corp. Common Stock (par value $0.01 per share)Great Ajax Corp. • October 3rd, 2016 • Real estate investment trusts • New York
Great Ajax Corp., a Maryland corporation (the “Company”), Great Ajax Operating Partnership LP, a Delaware limited partnership (the “Operating Partnership”), and Thetis Asset Management LLC, a Delaware limited liability company (the “Manager”), each confirms its agreement (this “Agreement”), with FBR Capital Markets & Co. (the “Agent”), as follows:
PHYSICIANS REALTY TRUST Common Shares ($0.01 par value per share) At Market Issuance Sales AgreementPhysicians Realty Trust • August 19th, 2014 • Real estate investment trusts • New York
Physicians Realty Trust, a Maryland real estate investment trust (the “Company”), and Physicians Realty L.P., a Delaware limited partnership (the “Operating Partnership”), confirm their agreement (this “Agreement”), with RBC Capital Markets, LLC (“Agent”), as follows:
